Retrovirology

Papers
(The median citation count of Retrovirology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Comparative analysis of human microglial models for studies of HIV replication and pathogenesis34
Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluat30
Rotten to the core: antivirals targeting the HIV-1 capsid core26
HIV-1 capsid exploitation of the host microtubule cytoskeleton during early infection24
Benefits and limitations of humanized mice in HIV persistence studies24
The HIV-1 capsid and reverse transcription23
A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection22
Dynamic nanopore long-read sequencing analysis of HIV-1 splicing events during the early steps of infection21
Arsenic trioxide (As2O3) as a maintenance therapy for adult T cell leukemia/lymphoma20
Identification of the distribution of human endogenous retroviruses K (HML-2) by PCR-based target enrichment sequencing20
Extracellular vesicles from HTLV-1 infected cells modulate target cells and viral spread20
Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection19
Humanized Mice for Infectious and Neurodegenerative disorders17
MxB impedes the NUP358-mediated HIV-1 pre-integration complex nuclear import and viral replication cooperatively with CPSF616
Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure15
Koala retrovirus diversity, transmissibility, and disease associations14
M-Sec facilitates intercellular transmission of HIV-1 through multiple mechanisms14
Defective HIV-1 genomes and their potential impact on HIV pathogenesis14
HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules14
DDX5 potentiates HIV-1 transcription as a co-factor of Tat13
Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitors12
HIV infection of non-classical cells in the brain12
Impact of HIV-1 CRF55_01B infection on the evolution of CD4 count and plasma HIV RNA load in men who have sex with men prior to antiretroviral therapy11
HIV and the tuberculosis “set point”: how HIV impairs alveolar macrophage responses to tuberculosis and sets the stage for progressive disease10
Trim28 acts as restriction factor of prototype foamy virus replication by modulating H3K9me3 marks and destabilizing the viral transactivator Tas10
Alpha-enolase in viral target cells suppresses the human immunodeficiency virus type 1 integration9
Co-receptor signaling in the pathogenesis of neuroHIV9
Anti-inflammatory effects of recreational marijuana in virally suppressed youth with HIV-1 are reversed by use of tobacco products in combination with marijuana9
Generation and validation of a highly sensitive bioluminescent HIV-1 reporter vector that simplifies measurement of virus release8
Advancing our understanding of HIV co-infections and neurological disease using the humanized mouse8
Addressing an HIV cure in LMIC8
Seroprevalence of human T-lymphotropic virus infection among blood donors in China: a first nationwide survey8
YTHDC1 regulates distinct post-integration steps of HIV-1 replication and is important for viral infectivity8
Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma8
Moving beyond the mousetrap: current and emerging humanized mouse and rat models for investigating prevention and cure strategies against HIV infection and associated pathologies8
HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina7
Vpx enhances innate immune responses independently of SAMHD1 during HIV-1 infection7
Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants7
A novel positive feedback-loop between the HTLV-1 oncoprotein Tax and NF-κB activity in T-cells7
Derivation and characterization of an HIV-1 mutant that rescues IP6 binding deficiency7
Influence of the amino-terminal sequence on the structure and function of HIV integrase7
Comprehensive identification and characterization of the HERV-K (HML-9) group in the human genome7
Editing out HIV: application of gene editing technology to achieve functional cure6
HIV-2/SIV Vpx antagonises NF-κB activation by targeting p656
HIV-1 integrase binding to genomic RNA 5′-UTR induces local structural changes in vitro and in virio6
Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features6
Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency6
An ancient retroviral RNA element hidden in mammalian genomes and its involvement in co-opted retroviral gene regulation5
Functional properties and sequence variation of HTLV-1 p135
Biomolecular condensates: insights into early and late steps of the HIV-1 replication cycle5
Integration of SARS-CoV-2 RNA in infected human cells by retrotransposons: an unlikely hypothesis and old viral relationships5
Comparison of pathological clotting using haematological, functional and morphological investigations in HIV-positive and HIV-negative patients with deep vein thrombosis5
Frequent horizontal and mother-to-child transmission may contribute to high prevalence of STLV-1 infection in Japanese macaques5
CRISPR/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection5
No evidence of bovine leukemia virus proviral DNA and antibodies in human specimens from Japan5
Increased HIV-1 pretreatment drug resistance with consistent clade homogeneity among ART-naive HIV-1 infected individuals in Ethiopia4
A novel class III endogenous retrovirus with a class I envelope gene in African frogs with an intact genome and developmentally regulated transcripts in Xenopus tropicalis4
An emerging and variant viral promoter of HIV-1 subtype C exhibits low-level gene expression noise4
Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda4
P-selectin glycoprotein ligand-1 (PSGL-1/CD162) is incorporated into clinical HIV-1 isolates and can mediate virus capture and subsequent transfer to permissive cells4
Modulation of human endogenous retroviruses and cytokines expression in peripheral blood mononuclear cells from autistic children and their parents3
DNA topoisomerase 1 represses HIV-1 promoter activity through its interaction with a guanine quadruplex present in the LTR sequence3
Immunoescape of HIV-1 in Env-EL9 CD8 + T cell response restricted by HLA-B*14:02 in a Non progressor who lost twenty-seven years of HIV-1 control3
Arginyl-tRNA-protein transferase 1 contributes to governing optimal stability of the human immunodeficiency virus type 1 core3
Origin and functional role of antisense transcription in endogenous and exogenous retroviruses3
Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG3
Innate immune regulation in HIV latency models3
Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators3
HIVIntact: a python-based tool for HIV-1 genome intactness inference3
Pericyte infection by HIV-1: a fatal attraction3
Elevated levels of inflammatory plasma biomarkers are associated with risk of HIV infection3
Increased expression of CDKN1A/p21 in HIV-1 controllers is correlated with upregulation of ZC3H12A/MCPIP13
Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization3
0.019582033157349